299 related articles for article (PubMed ID: 9857092)
1. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP).
Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT
J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064.
Bowman KJ; White A; Golding BT; Griffin RJ; Curtin NJ
Br J Cancer; 1998 Nov; 78(10):1269-77. PubMed ID: 9823965
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent.
Zhu GD; Gandhi VB; Gong J; Thomas S; Luo Y; Liu X; Shi Y; Klinghofer V; Johnson EF; Frost D; Donawho C; Jarvis K; Bouska J; Marsh KC; Rosenberg SH; Giranda VL; Penning TD
Bioorg Med Chem Lett; 2008 Jul; 18(14):3955-8. PubMed ID: 18586490
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes.
Tentori L; Portarena I; Vernole P; Gold B; Graziani G
Cancer Chemother Pharmacol; 2002 Mar; 49(3):217-24. PubMed ID: 11935214
[TBL] [Abstract][Full Text] [Related]
6. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
[TBL] [Abstract][Full Text] [Related]
7. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.
Menear KA; Adcock C; Boulter R; Cockcroft XL; Copsey L; Cranston A; Dillon KJ; Drzewiecki J; Garman S; Gomez S; Javaid H; Kerrigan F; Knights C; Lau A; Loh VM; Matthews IT; Moore S; O'Connor MJ; Smith GC; Martin NM
J Med Chem; 2008 Oct; 51(20):6581-91. PubMed ID: 18800822
[TBL] [Abstract][Full Text] [Related]
8. Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP).
Griffin RJ; Pemberton LC; Rhodes D; Bleasdale C; Bowman K; Calvert AH; Curtin NJ; Durkacz BW; Newell DR; Porteous JK
Anticancer Drug Des; 1995 Sep; 10(6):507-14. PubMed ID: 7575991
[No Abstract] [Full Text] [Related]
9. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Miyashiro J; Woods KW; Park CH; Liu X; Shi Y; Johnson EF; Bouska JJ; Olson AM; Luo Y; Fry EH; Giranda VL; Penning TD
Bioorg Med Chem Lett; 2009 Aug; 19(15):4050-4. PubMed ID: 19553114
[TBL] [Abstract][Full Text] [Related]
11. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.
Tikhe JG; Webber SE; Hostomsky Z; Maegley KA; Ekkers A; Li J; Yu XH; Almassy RJ; Kumpf RA; Boritzki TJ; Zhang C; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR
J Med Chem; 2004 Oct; 47(22):5467-81. PubMed ID: 15481984
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
[TBL] [Abstract][Full Text] [Related]
15. Effect of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose) polymerase, on cultured tumor cells.
Weltin D; Marchal J; Dufour P; Potworowski E; Oth D; Bischoff P
Oncol Res; 1994; 6(9):399-403. PubMed ID: 7703525
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.
Le TV; Suh JH; Kim N; Park HJ
Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835
[TBL] [Abstract][Full Text] [Related]
17. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
18. Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase.
White AW; Almassy R; Calvert AH; Curtin NJ; Griffin RJ; Hostomsky Z; Maegley K; Newell DR; Srinivasan S; Golding BT
J Med Chem; 2000 Nov; 43(22):4084-97. PubMed ID: 11063605
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S
Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]